Sharma J, Khatav SK. Polymyxin B Hemoperfusion in Sepsis: A Possible Silver Lining to the Dark Clouds? Indian J Crit Care Med 2024;28(10):903-905.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11471985 | PMC |
| http://dx.doi.org/10.5005/jp-journals-10071-24816 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations.
Indian J Crit Care Med
January 2025
Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India.
Angadi VM, Kambagiri P, Jindal A. Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations. Indian J Crit Care Med 2025;29(1):90.
View Article and Find Full Text PDFAnalysis of Trends and Influencing Factors of Cytokine-Adsorbing Therapies: A Nationwide Ecological Study in Japan.
Cureus
November 2024
Department of Emergency and Critical Care Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, JPN.
Background: Cytokine-adsorption therapy has garnered attention as a potential treatment for conditions such as sepsis, although supporting evidence remains limited. Consequently, its utilization is expected to vary significantly across regions. To date, no ecological studies have investigated this regional heterogeneity.
View Article and Find Full Text PDFDirect hemoperfusion with polymyxin B immobilized fiber column (PMX) treatment for acute exacerbation of idiopathic pulmonary fibrosis: A prospective multicenter cohort study.
Respir Investig
January 2025
Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-Higashi, Kanazawa-ku, Yokohama, Kanagawa, 236-0051, Japan.
Article Synopsis
- - A study investigated the effects of polymyxin B-immobilized fiber column (PMX) treatment on patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF), who typically have a poor prognosis.
- - Results showed a survival rate of 65% at day 28 after PMX treatment, which is significantly higher than the usual 40% survival rate seen with conventional treatments.
- - The study concluded that PMX treatment is safe and potentially improves oxygenation and overall prognosis for AE-IPF patients.
Risk Factors for Postoperative Mortality in Patients with Colorectal Diverticular Perforation.
J Anus Rectum Colon
October 2024
Department of Surgery, Fukuoka Tokushukai Hospital, Kasuga, Japan.
Article Synopsis
- The study examined the effectiveness of polymyxin B-immobilized fiber column direct hemoperfusion (PMX-DHP) in patients with surgically treated perforated colorectal diverticula, finding that the overall prognosis is poor.
- Analysis of 46 patients revealed that those in the mortality group had significant preoperative risk factors, including antithrombotic drug use and elevated lactate levels, associated with higher chances of post-surgery mortality.
- PMX-DHP was more frequently used in patients with severe conditions, but it did not improve outcomes, indicating its limited efficacy for those severely affected.
Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis.
Indian J Crit Care Med
October 2024
Department of Nephrology, Medicine and Nephrology, Command Hospital (SC), Pune, India.
Objectives: To study the efficacy of polymyxin B hemoperfusion in addition to standard care for sepsis treatment.
Materials And Methods: Fifty sepsis patients (mean age 54.26 ± 14.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!